Freelite与Seralite两种血清游离轻链定量方法在临床实验室的评估:以免疫分析切换为视角
该研究在10个月期间对临床实验室接收的189例患者样本同时使用Freelite和Seralite进行血清游离轻链定量,比较两种方法的定量结果及其对患者结果解读的影响。多发性骨髓瘤及相关浆细胞疾病和MGUS一致性良好,AL淀粉样变性一致性较差。尽管定量存在系统差异,两种平台在临床解读上总体一致,Seralite作为无需大型昂贵分析仪的快速检测可能在特定实验室适用。
要点
- 多发性骨髓瘤及相关浆细胞疾病和MGUS一致性良好,AL淀粉样变性一致性较差。
- Bland-Altman图显示平均偏倚小,但FLC浓度升高时方法间变异增大。
核心结论
- 尽管两种sFLC平台定量存在差异,但总体在临床解读上的一致性可见。
- Seralite作为无需大型昂贵分析仪的快速检测,可能在特定实验室适用于院内检测。
研究设计与样本
- 在10个月期间对临床实验室接收的样本同时进行Freelite和Seralite sFLC定量。
- 纳入患者N=189,包括多发性骨髓瘤及相关浆细胞肿瘤、MGUS、AL淀粉样变性和肾功能损害。
- 评估两种方法间的sFLC定量和临床一致性。
主要发现
- 多发性骨髓瘤及相关浆细胞疾病和MGUS一致性良好,AL淀粉样变性一致性较差。
- Bland-Altman图显示平均偏倚小,但FLC浓度升高时方法间变异增大。
- Passing-Bablok分析确认方法间定量存在系统差异。
临床怎么用
- 在考虑切换sFLC免疫分析方法时,需注意方法间定量存在系统差异但临床解读总体一致。
- Seralite作为快速检测,可能在特定实验室用于院内sFLC检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum free light chain (sFLC) quantitation is central for plasma cell dyscrasias. Several assays are available and switching sFLC methods may be advantageous in certain laboratories. This study performed Freelite and Seralite simultaneously for samples received by the clinical laboratory over a 10 month period and compared quantitation and its impact on interpretation of patient results. METHODS: Patients (N = 189) included multiple myeloma (MM) and related plasma cell cancers, monoclonal gammopathy of unknown significance (MGUS), AL amyloidosis and renal impairment. sFLC quantitation and clinical agreement was assessed between methods. RESULTS: Clinical agreement was substantial at diagnosis (κ = 0.647, p < .01) and moderate for monitoring (κ = 0.591, p < .01). Good concordance was seen for MM and related plasma disorders and MGUS, with poorer agreement seen for AL amyloidosis. Case studies illustrated agreement in pattern of myeloma disease activity. Bland-Atman plots showed small mean bias but increasing variation between methods with increasing FLC concentrations. Passing-Bablok analysis confirmed systematic differences in quantitation between methods. CONCLUSIONS: Despite differences in quantitation, overall, agreement was seen between the different sFLC platforms in relation to the clinical interpretation. As a rapid test without the need for large and expensive analysers, Seralite may be highly applicable in certain laboratories to enable in-house testing.
引用
- Heaney JLJ, Ackermann F, Paunet-Bobo M, et al. Evaluation of two serum free light chain quantitation methods, Freelite and Seralite, in the clinical laboratory with a view to switching immunoassay. Clin Chim Acta. 2020. PMID: 32702434. doi:10.1016/j.cca.2020.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。